Format

Send to

Choose Destination
Australas J Dermatol. 2017 May;58(2):155-159. doi: 10.1111/ajd.12600. Epub 2017 Mar 1.

Consensus statement for the treatment of infantile haemangiomas with propranolol.

Author information

1
Royal Children's Hospital, Melbourne, Victoria, Australia.
2
Waikato Hospital, Hamilton, New Zealand.
3
University of New South Wales School of Women's and Children's Health, Randwick, New South Wales, Australia.
4
The Lady Cilentro Children's Hospital, Brisbane, Queensland, Australia.
5
Canberra Hospital, Canberra, Australian Capital Territory, Australia.
6
University of Sydney, Sydney, New South Wales, Australia.
7
Princess Margaret Hospital for Children, Perth, Western Australia, Australia.
8
Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.
9
Children's Hospital at Westmead, Sydney, Australia.
10
St George Hospital Campus, Sydney, New South Wales, Australia.
11
Starship Children's Hospital, Auckland, New Zealand.
12
John Hunter Children's Hospital, Newcastle, New South Wales, Australia.
13
Gillies McIndoe Research Institute, Wellington, New Zealand.
14
Sydney Children's Hospital, Sydney, New South Wales, Australia.
15
Women's and Children's Hospital, Adelaide, South Australia, Australia.

Abstract

Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.

KEYWORDS:

Australian; New Zealand; beta-blocker; consensus; hemangioma; infantile haemangioma; propranolol; vascular anomaly

PMID:
28251611
DOI:
10.1111/ajd.12600
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center